The MarketReader Minute
💊 Biotech Sector Insights | BIIB -1.8%
BIIB faced legal action, MRNA submitted updated COVID-19 vaccines for FDA review potentially impacting stock performance positively, and CRL received Neutral coverage with a price target from an analyst possibly affecting movement today.